US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

NOVONESIS A S

65.50

-0.2000-0.30%

Volume:13.51K

Turnover:888.63K

Market Cap:30.43B

PE:40.60

High:66.59

Open:66.59

Low:64.60

Close:65.70

Loading ...

Overview Company News Filings

Novonesis price target lowered to DKK 485 from DKK 515 at Berenberg

Is Idaho Strategic Resources (IDR) Outperforming Other Basic Materials Stocks This Year?

Resolutions from the Annual General Meeting 2025

Novonesis price target lowered to DKK 490 from DKK 500 at Barclays

Are Basic Materials Stocks Lagging AngloGold Ashanti PLC (AU) This Year?

Election of employee representatives to the Board of Directors

Initiation of share buyback program

AXTA or NVZMY: Which Is the Better Value Stock Right Now?

Novonesis (Novozymes) B (NVZMF) (Q4 2024) Earnings Call Highlights: Strong Organic Sales Growth ...

12M 2024: Novonesis delivers strong full-year results and expects continued growth in 2025

12M 2024 Company announcement

Change to the Executive Leadership Team

Novonesis to acquire dsm-firmenich’s share of the Feed Enzyme Alliance

Here's how Trump could impose tariffs on Denmark in a bid to control Greenland

Novonesis price target lowered to DKK 455 from DKK 460 at UBS

Novonesis price target lowered to DKK 515 from DKK 530 at Berenberg

Novonesis price target lowered to DKK 500 from DKK 525 at Barclays

Q3 update: Novonesis delivers strong Q3 results and now expects full-year organic sales growth at the upper end of 7-8%

Trading statement 9M 2024

AXTA vs. NVZMY: Which Stock Is the Better Value Option?

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NVZMY/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NVZMY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVZMY\",,,,,undefined,":{"symbol":"NVZMY","market":"US","secType":"STK","nameCN":"NOVONESIS A S","latestPrice":65.5,"timestamp":1746475200000,"preClose":65.7,"halted":0,"volume":13508,"delay":15,"floatShares":345188430,"shares":464616092,"eps":1.613472,"marketStatus":"Pre-Mkt","change":-0.2,"latestTime":"05-05 16:00:00 EDT Delay","open":66.59,"high":66.59,"low":64.6,"amount":888627.9504999997,"amplitude":0.030289,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":1.613472,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1746538200000},"marketStatusCode":1,"adr":0,"adrRate":1,"exchange":"PINK LIMITED","adjPreClose":65.5,"volumeRatio":1.0625678544323574},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVZMY\",,,,,undefined,":{"symbol":"NVZMY","floatShares":345188430,"roa":"5.54%","roe":"4.67%","lyrEps":1.61875,"volumeRatio":1.0625678544323574,"shares":464616092,"dividePrice":0.940277,"high":66.59,"amplitude":0.030289,"preClose":65.7,"low":64.6,"week52Low":53.95,"pbRate":"2.40","psRate":"7.01","week52High":72.5,"institutionHeld":0,"latestPrice":65.5,"eps":1.613472,"divideRate":0.014355,"volume":13508,"delay":15,"ttmEps":1.613472,"open":66.59,"prevYearClose":56.5399,"prevWeekClose":65.7,"prevMonthClose":64.91,"prevQuarterClose":58.41,"fiveDayClose":62.99,"twentyDayClose":60.91,"sixtyDayClose":57,"earningDate":1746633600000,"earningTime":"盘前"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVZMY\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529558560","title":"Novonesis price target lowered to DKK 485 from DKK 515 at Berenberg","url":"https://stock-news.laohu8.com/highlight/detail?id=2529558560","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529558560?lang=en_us&edition=fundamental","pubTime":"2025-04-23 01:31","pubTimestamp":1745343077,"startTime":"0","endTime":"0","summary":"Berenberg analyst Sebastian Bray lowered the firm’s price target on Novonesis (NVZMY) to DKK 485 from DKK 515 and keeps a Buy rating on the shares....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novonesis-price-target-lowered-to-dkk-485-from-dkk-515-at-berenberg?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novonesis-price-target-lowered-to-dkk-485-from-dkk-515-at-berenberg?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVZMY","BK4109"],"gpt_icon":0},{"id":"2525502390","title":"Is Idaho Strategic Resources (IDR) Outperforming Other Basic Materials Stocks This Year?","url":"https://stock-news.laohu8.com/highlight/detail?id=2525502390","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525502390?lang=en_us&edition=fundamental","pubTime":"2025-04-07 21:40","pubTimestamp":1744033207,"startTime":"0","endTime":"0","summary":"For those looking to find strong Basic Materials stocks, it is prudent to search for companies in the group that are outperforming their peers. Idaho Strategic Resources, Inc.  is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole?By taking a look at the stock's year-to-date performance in comparison to its Basic Materials peers, we might be able to answer that question.Idaho Strategic Resources, Inc. is one of 232 individual stocks in the Basic Materials sector. Collectively, these companies sit at #14 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/idaho-strategic-resources-idr-outperforming-134007510.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NVZMY","IDR","ARKG","NVZMF"],"gpt_icon":0},{"id":"2524729388","title":"Resolutions from the Annual General Meeting 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2524729388","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524729388?lang=en_us&edition=fundamental","pubTime":"2025-04-03 23:43","pubTimestamp":1743694980,"startTime":"0","endTime":"0","summary":"Today, the Annual General Meeting of Novonesis  was conducted.Approval of distribution of profit with payment of an ordinary dividend of DKK 4.20  per A and B share. In addition to this year-end dividend, an interim dividend of DKK 2.00  was disbursed on September 3, 2024.Approval of the remuneration of members of the Board of Directors for 2025. Re-election of Cornelis  de Jong as Chair of the Board of Directors. Re-election of Heine Dalsgaard as a member of the Board of Directors and election as new Vice Chair. Re-election of Lise Kaae, Kasim Kutay, Kevin Lane, Morten Otto Alexander Sommer, and Kim Stratton as members of the Board of Directors. Election of Monila Kothari as a new member of the Board of Directors. Approval to renew the authorizations to the Board of Directors to implement capital increases. Approval of the authorization to the Board of Directors to distribute extraordinary dividends. Composition of the Board of Directors and its committeesAfter the Annual General Meet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/resolutions-annual-general-meeting-2025-154300077.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4109","NVZMF","NVZMY"],"gpt_icon":0},{"id":"2523686281","title":"Novonesis price target lowered to DKK 490 from DKK 500 at Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2523686281","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523686281?lang=en_us&edition=fundamental","pubTime":"2025-03-29 01:30","pubTimestamp":1743183009,"startTime":"0","endTime":"0","summary":"Barclays lowered the firm’s price target on Novonesis (NVZMY) to DKK 490 from DKK 500 and keeps an Overweight rating on the shares. Published first...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novonesis-price-target-lowered-to-dkk-490-from-dkk-500-at-barclays?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novonesis-price-target-lowered-to-dkk-490-from-dkk-500-at-barclays?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVZMY","BK4109"],"gpt_icon":0},{"id":"2520957577","title":"Are Basic Materials Stocks Lagging  AngloGold Ashanti PLC (AU) This Year?","url":"https://stock-news.laohu8.com/highlight/detail?id=2520957577","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520957577?lang=en_us&edition=fundamental","pubTime":"2025-03-17 21:40","pubTimestamp":1742218808,"startTime":"0","endTime":"0","summary":"For those looking to find strong Basic Materials stocks, it is prudent to search for companies in the group that are outperforming their peers. Has AngloGold Ashanti  been one of those stocks this year?A quick glance at the company's year-to-date performance in comparison to the rest of the Basic Materials sector should help us answer this question.AngloGold Ashanti is a member of our Basic Materials group, which includes 232 different companies and currently sits at #15 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. AngloGold Ashanti is currently sporting a Zacks Rank of #1 .One other Basic Materials stock ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/basic-materials-stocks-lagging-anglogold-134008163.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0345780281.USD","LU0498741890.SGD","LU0724618789.USD","BK4017","LU0368265764.SGD","LU1223082519.USD","BK4570","NVZMY","BK4588","BK4109","BK4585","BK4522","LU1223082196.USD","BK4533","BK4544","LU0055631609.USD","LU0496367417.USD","LU0345780521.USD","NVZMF","AU","LU0498741114.HKD","LU0788108826.HKD","LU1223083913.SGD","ARKG"],"gpt_icon":0},{"id":"2517919032","title":"Election of employee representatives to the Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2517919032","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517919032?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:52","pubTimestamp":1741179120,"startTime":"0","endTime":"0","summary":"The employees have conducted the election of employee representatives to the Board of Directors of Novonesis .The following employee representatives  were elected for the next four years:. Robert Nddeskov Jensen, Senior Operator - newly elected. Frederikke Rose Spenner, Production Engineer - newly elected. As alternates to the employee representatives to the Board of Directors, the employees elected Mikael Barfred, Heidi Gelt and Ida Carlsen Virklund .As re-elected, Preben Nielsen will continue in the Board of Directors, and the newly elected employee representatives will join the Board of Directors following the Annual General Meeting of Novonesis on April 3, 2025. At the same event, the term of election for the former employee representatives, Lena Bech Holskov, Anders Hentze Knudsen, and Jens bro will end.The term of Board Observer Kim Ib Srensen will also end following the Annual General Meeting of Novonesis on April 3, 2025.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/election-employee-representatives-board-directors-125200420.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4109","NVZMF","NVZMY"],"gpt_icon":0},{"id":"2517964007","title":"Initiation of share buyback program","url":"https://stock-news.laohu8.com/highlight/detail?id=2517964007","media":"GlobeNewswire","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517964007?lang=en_us&edition=fundamental","pubTime":"2025-03-05 15:42","pubTimestamp":1741160520,"startTime":"0","endTime":"0","summary":"On March 5, 2025, Novonesis will initiate a share buyback program as announced in Company Announcement No. 3 of February 26, 2025. Under the program, Novonesis will buy back B shares worth up to EUR 100 million in total during the remainder of 2025, corresponding to around 1.7 million B shares at the current share price. The program is contingent upon no major strategic initiatives being decided upon that will require a significant amount of capital.The shares acquired in the program will be used to meet obligations arising from employee share-based incentive programs.The maximum number of shares to be purchased by the company per daily market session will be equivalent to no more than 25% of the average volume of shares in the company traded on NASDAQ OMX Copenhagen during the preceding 20 business days. The program will run in accordance with the European Commission Regulation  No. 596/2014 of 16 April 2014 , and the European Commission Delegated Regulation  No. 1052/2016 of 8 March ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/initiation-share-buyback-program-074200554.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4109","NVZMF","NVZMY","BK4156"],"gpt_icon":0},{"id":"2516309654","title":"AXTA or NVZMY: Which Is the Better Value Stock Right Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2516309654","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516309654?lang=en_us&edition=fundamental","pubTime":"2025-03-04 00:40","pubTimestamp":1741020025,"startTime":"0","endTime":"0","summary":"Investors with an interest in Chemical - Specialty stocks have likely encountered both Axalta Coating Systems  and Novozymes A/S . But which of these two stocks is more attractive to value investors?We'll need to take a closer look to find out.Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The Zacks Rank is a proven strategy that targets companies with positive earnings estimate revision trends, while our Style Scores work to grade companies based on specific traits.Axalta Coating Systems and Novozymes A/S are sporting Zacks Ranks of #1  and #2 , respectively, right now. Investors should feel comfortable knowing that AXTA likely has seen a stronger improvement to its earnings outlook than NVZMY has recently. However, value investors will care about much more than just this.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/axta-nvzmy-better-value-stock-164025340.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0006061336.USD","BK4109","AXTA","LU1074936037.SGD","NVZMY","BK4561","NVZMF"],"gpt_icon":0},{"id":"2514235908","title":"Novonesis (Novozymes) B (NVZMF) (Q4 2024) Earnings Call Highlights: Strong Organic Sales Growth ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2514235908","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514235908?lang=en_us&edition=fundamental","pubTime":"2025-02-27 15:02","pubTimestamp":1740639747,"startTime":"0","endTime":"0","summary":"Organic Sales Growth: 8% for 2024, with a 7% growth in Q4.Pro Forma Adjusted EBITDA Margin: 36.1% for 2024, an increase of 2.3 percentage points from 2023.Gross Margin: 47.4% reported, 56.7% adjusted for purchase price allocation impacts.Revenue Synergy Program: On track for DKK200 million run rate, with initial contributions expected in 2025.Food & Health Biosolutions Organic Sales Growth: 7% for 2024 and Q4.Household Care Organic Sales Growth: 13% for 2024.Adjusted Earnings Per Share: EUR1.28, a decrease of 15% compared to the previous year.2025 Organic Sales Growth Outlook: 5% to 8%, with a 37% to 38% adjusted EBITDA margin expected.GuruFocus has detected 4 Warning Signs with NVZMF.For the complete transcript of the earnings call, please refer to the full earnings call transcript.Novonesis  B  achieved an 8% organic sales growth in 2024, driven by a 6% volume increase and a 2% contribution from pricing.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/novonesis-novozymes-b-nvzmf-q4-070227557.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NVZMY","NVZMF"],"gpt_icon":0},{"id":"2514600197","title":"12M 2024: Novonesis delivers strong full-year results and expects continued growth in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2514600197","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514600197?lang=en_us&edition=fundamental","pubTime":"2025-02-26 15:04","pubTimestamp":1740553440,"startTime":"0","endTime":"0","summary":"Novonesis delivers 8% organic sales growth with an adjusted EBITDA margin of 36.1% in 2024. For 2025, Novonesis presents an outlook of 5-8% organic sales growth with an adjusted EBITDA margin of 37-38%.COPENHAGEN, Denmark – February 26, 2025. In the 2024 financial year, Novonesis delivers 8% organic sales growth with an adjusted EBITDA margin at 36.1%. The sales growth is driven by both Food & Health Biosolutions and Planetary Health Biosolutions. Volumes have increased by ~6% with pricing contributing ~2% in 2024.Divisional sales performanceFor the full 2024 financial year, Food & Health Biosolutions grew 7% organically, while Planetary Health Biosolutions grew 9% organically.In Food & Health Biosolutions, Food & Beverages grew 8% organically driven by strong growth in Dairy and solid development in Baking. In Human Health, organic sales growth was 5% in line with expectations.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/12m-2024-novonesis-delivers-strong-070400515.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NVZMY","BK4109","NVZMF"],"gpt_icon":0},{"id":"2514612009","title":"12M 2024 Company announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=2514612009","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514612009?lang=en_us&edition=fundamental","pubTime":"2025-02-26 14:58","pubTimestamp":1740553080,"startTime":"0","endTime":"0","summary":"2024 organic pro forma sales growth of 8%, with pro forma adjusted EBITDA margin of 36.1%. 2025 outlook of 5-8% organic pro forma sales growth and 37-38% adjusted EBITDA margin.2024 organic pro forma sales growth of 8%  and 8% on IFRS reported basis . Food & Health Biosolutions at 7%, and Planetary Health Biosolutions at 9%.2024 pro forma adjusted EBITDA margin of 36.1% , with 35.2% for Food & Health Biosolutions and 36.8% for Planetary Health Biosolutions. 2024 adjusted EBITDA margin on IFRS reported base of 36.2% .2024 pro forma cash flow from operating activities at EUR 1,032.5 million, including the positive one-off item in H1.2024 contribution from cost synergies at ~1pp on pro forma adjusted EBITDA margin at an 80% run rate of the 3-year EUR 80-90m target.Net debt/EBITDA at 1.4x year-end 2024 compared to 1.2x year-end 2023.Food & Health Biosolutions realized pro forma organic sales growth of 7% . Pro forma sales were EUR 1,770.9 million, an increase of 3% . Food & Beverages grew ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/12m-2024-company-announcement-065800175.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NVZMF","NVZMY","BK4109"],"gpt_icon":0},{"id":"2513699932","title":"Change to the Executive Leadership Team","url":"https://stock-news.laohu8.com/highlight/detail?id=2513699932","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513699932?lang=en_us&edition=fundamental","pubTime":"2025-02-21 19:24","pubTimestamp":1740137040,"startTime":"0","endTime":"0","summary":"Jacob Vishof Paulsen will be leaving his position as Executive Vice President of Food & Beverage Biosolutions, as he has accepted a role outside of Novonesis, effective March 31, 2025.Ester Baiget, President & CEO comments: “I want to thank Jacob for his strong leadership and commitment to Novonesis and our Food & Beverage Biosolutions business. Jacob has played an instrumental role in Novonesis. As a result of his contribution, the Food & Beverage Biosolutions business in Novonesis rests on a solid foundation with an extraordinary team and is uniquely positioned to drive continued growth and deliver innovative solutions to our customers. I wish Jacob all the best on his future journey.”Jacob joined Chr. Hansen in 2006 and became a member of the Corporate Leadership Team in 2013. During his tenure in Chr. Hansen, Jacob has held multiple global sales and business unit leadership positions and since 2019 been responsible for the Food Cultures & Enzymes business unit, before entering his ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/change-executive-leadership-team-112400389.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4120","TISI","BK4109","NVZMF","NVZMY"],"gpt_icon":0},{"id":"2510682051","title":"Novonesis to acquire dsm-firmenich’s share of the Feed Enzyme Alliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2510682051","media":"GlobeNewswire","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510682051?lang=en_us&edition=fundamental","pubTime":"2025-02-11 14:13","pubTimestamp":1739254380,"startTime":"0","endTime":"0","summary":"Novonesis has reached an agreement with dsm-firmenich to dissolve the Feed Enzyme Alliance and take over its sales and distribution activities, in exchange for a total cash consideration of EUR 1.5 billion. After more than 25 years of successful collaboration, a strategic repositioning at dsm-firmenich allowed this opportunity to materialize. This acquisition is aligned with Novonesis’ growth strategy and expands its presence across the animal biosolutions value chain. Financially, this transaction is accretive to revenue growth, adjusted EBITDA margin and adjusted EPS excl. amortization, with attractive revenue synergies.Attractive growth potential, further enhanced by revenue synergies: The total animal biosolutions market is projected to grow at a mid-single digit CAGR driven by growing protein demand, land scarcity and environmental concerns. This acquisition will accelerate Novonesis’ sales growth of animal biosolutions by a low-single-digit CAGR above market growth while also del","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/novonesis-acquire-dsm-firmenich-share-061300936.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NVZMF","NVZMY","BK4109"],"gpt_icon":0},{"id":"2502083309","title":"Here's how Trump could impose tariffs on Denmark in a bid to control Greenland","url":"https://stock-news.laohu8.com/highlight/detail?id=2502083309","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502083309?lang=en_us&edition=fundamental","pubTime":"2025-01-09 05:08","pubTimestamp":1736370480,"startTime":"0","endTime":"0","summary":"The president-elect could rely on powers related to national security. President-elect Donald Trump threatened Tuesday to place new tariffs on imports from Denmark unless the country gives up control of Greenland, news that dented the stocks of some of Denmark's most important companies and underscored Trump's focus on geopolitical competition.Trump said that U.S. control of Greenland was needed for national and economic security and that he wouldn't rule out the use of military force to take the world's largest island, which is a Danish territory.\"When I think of these territorial aspirations, I see a China thread through all of them,\" Steve Pavlick, a former Trump Treasury official who is now a policy analyst at Mindset, told MarketWatch. \"Greenland also has a lot of natural resources and critical mineral wealth\" that could be useful in any future conflict with China, he added.Other possible legal tools include what are known as Section 301 and 232 powers, which were used during Trum","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DNKEY","BK4182","LU0154236417.USD","EDEN","BK4532","BK4202","BK4599","BK4207","LU1093756168.USD","BK4198","NVZMY","PANDY","NVO","IE00BKVL7J92.USD","LU1093756325.SGD","BK4007","IE00BZ1G4Q59.USD","CLPBY","BK4585","BK4588","BK4109","VWDRY"],"gpt_icon":1},{"id":"2492131260","title":"Novonesis price target lowered to DKK 455 from DKK 460 at UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2492131260","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492131260?lang=en_us&edition=fundamental","pubTime":"2024-12-19 01:50","pubTimestamp":1734544241,"startTime":"0","endTime":"0","summary":"UBS lowered the firm’s price target on Novonesis (NVZMY) to DKK 455 from DKK 460 and keeps a Neutral rating on the shares. Published first on TheFl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novonesis-price-target-lowered-to-dkk-455-from-dkk-460-at-ubs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novonesis-price-target-lowered-to-dkk-455-from-dkk-460-at-ubs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4109","NVZMY"],"gpt_icon":0},{"id":"2484983202","title":"Novonesis price target lowered to DKK 515 from DKK 530 at Berenberg","url":"https://stock-news.laohu8.com/highlight/detail?id=2484983202","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484983202?lang=en_us&edition=fundamental","pubTime":"2024-11-19 04:21","pubTimestamp":1731961260,"startTime":"0","endTime":"0","summary":"Berenberg lowered the firm’s price target on Novonesis (NVZMY) to DKK 515 from DKK 530 and keeps a Buy rating on the shares. Published first on The...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novonesis-price-target-lowered-to-dkk-515-from-dkk-530-at-berenberg?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novonesis-price-target-lowered-to-dkk-515-from-dkk-530-at-berenberg?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4109","NVZMY"],"gpt_icon":0},{"id":"2483586420","title":"Novonesis price target lowered to DKK 500 from DKK 525 at Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2483586420","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483586420?lang=en_us&edition=fundamental","pubTime":"2024-11-16 02:55","pubTimestamp":1731696942,"startTime":"0","endTime":"0","summary":"Barclays lowered the firm’s price target on Novonesis (NVZMY) to DKK 500 from DKK 525 and keeps an Overweight rating on the shares. Published first...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novonesis-price-target-lowered-to-dkk-500-from-dkk-525-at-barclays?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novonesis-price-target-lowered-to-dkk-500-from-dkk-525-at-barclays?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVZMY","BK4109"],"gpt_icon":0},{"id":"2481947852","title":"Q3 update: Novonesis delivers strong Q3 results and now expects full-year organic sales growth at the upper end of 7-8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481947852","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481947852?lang=en_us&edition=fundamental","pubTime":"2024-11-07 15:02","pubTimestamp":1730962920,"startTime":"0","endTime":"0","summary":"Following increasing demand in the first nine months of the 2024 financial year, Novonesis delivers 9% organic sales growth with a strong 11% organic sales growth in the third quarter. The strong performance has led Novonesis to now expect full-year organic sales growth to be at the upper end of the 7-8% range, and the adjusted EBITDA margin is confirmed to be between 35.5-36.5%.COPENHAGEN, Denmark – November 7, 2024. Novonesis delivers 9% organic sales growth, in the first nine months of the 2024 financial year.The sales growth is driven by both Food & Health Biosolutions and Planetary Health Biosolutions.Regional sales performanceIn the first nine months of 2024, organic pro forma sales in developed markets increased 6%, driven by growth in","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/yoOXbgn55UA.dsMXUkcYuw--~B/aD01Nzt3PTQ1MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/dbe717fbf6f756a3887149e62a2f5d33","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/yoOXbgn55UA.dsMXUkcYuw--~B/aD01Nzt3PTQ1MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/dbe717fbf6f756a3887149e62a2f5d33"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/q3-novonesis-delivers-strong-q3-070200879.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NVZMF","NVZMY"],"gpt_icon":0},{"id":"2481947837","title":"Trading statement 9M 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2481947837","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481947837?lang=en_us&edition=fundamental","pubTime":"2024-11-07 14:59","pubTimestamp":1730962740,"startTime":"0","endTime":"0","summary":"Organic pro forma sales growth of 9%, including 11% in the third quarter. Full-year organic sales growth outlook now expected at the upper end of the 7-8% range and the adjusted EBITDA margin confirmed between 35.5-36.5%.Pro forma sales performance Novonesis realized 9% pro forma organic sales growth for the first 9M 2024 . Volumes increased ~7%, and pricing contributed ~2%. Pro forma sales amounted to EUR 2,964.1 million, an increase of 6% . Emerging markets grew 14% organically, and developed markets increased 6%. Q3 sales growth was strong and positively impacted by customers' order timing.Planetary Health Biosolutions realized pro forma organic sales growth of 9% for 9M 2024 . Pro forma sales were EUR 1,627.0 million, an increase of 8% . Household Care grew 15%  organically and Agriculture, Energy & Tech grew 7%  organically.Reported  sales performance Novonesis reported 9% organic sales growth in 9M 2024 according to IFRS reporting. Reported sales in EUR were 2,852.1 million  mill","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/yoOXbgn55UA.dsMXUkcYuw--~B/aD01Nzt3PTQ1MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/dbe717fbf6f756a3887149e62a2f5d33","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/yoOXbgn55UA.dsMXUkcYuw--~B/aD01Nzt3PTQ1MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/dbe717fbf6f756a3887149e62a2f5d33"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/trading-statement-9m-2024-065900601.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4109","NVZMF","NVZMY"],"gpt_icon":0},{"id":"2481300745","title":"AXTA vs. NVZMY: Which Stock Is the Better Value Option?","url":"https://stock-news.laohu8.com/highlight/detail?id=2481300745","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481300745?lang=en_us&edition=fundamental","pubTime":"2024-11-05 00:40","pubTimestamp":1730738417,"startTime":"0","endTime":"0","summary":"Investors looking for stocks in the Chemical - Specialty sector might want to consider either Axalta Coating Systems  or Novozymes A/S . But which of these two stocks presents investors with the better value opportunity right now?There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The proven Zacks Rank emphasizes companies with positive estimate revision trends, and our Style Scores highlight stocks with specific traits.AXTA currently has a forward P/E ratio of 17.81, while NVZMY has a forward P/E of 34.48. We also note that AXTA has a PEG ratio of 0.83. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. NVZMY currently has a PEG ratio of 3.54.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/QOfludHza1dTKV8R6Coeiw--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/48ad4265c55e3ba7a1fb9148d6e717d9","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/QOfludHza1dTKV8R6Coeiw--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/48ad4265c55e3ba7a1fb9148d6e717d9"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/axta-vs-nvzmy-stock-better-164017490.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4109","NVZMY","LU0006061336.USD","AXTA","BK4561","LU1074936037.SGD","NVZMF"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":20,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVZMY\",params:#limit:5,,,undefined,":[{"date":"2025-04-07","symbol":"NVZMY","amount":0.610633,"announcedDate":"2025-03-10","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-07","defaultRemindTime":1744032600000,"name":"NOVONESIS A S","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-23","payableDate":"2025-04-07","currency":"USD","dateTimestamp":1743998400000,"payDate":"2025-04-23"},{"market":"US","date":"2025-02-26","symbol":"NVZMY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1740546000000,"reportTimeType":"","actualEps":null},{"date":"2024-09-09","symbol":"NVZMY","amount":0.29841,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-09-09","defaultRemindTime":1725888600000,"name":"NOVONESIS A S","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-09-18","payableDate":"2024-09-09","currency":"USD","dateTimestamp":1725854400000,"payDate":"2024-09-18"},{"market":"US","date":"2024-08-28","symbol":"NVZMY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1724817600000,"reportTimeType":"","actualEps":null},{"date":"2024-05-01","symbol":"NVZMY","amount":0.288508,"announcedDate":"2024-04-10","type":"dividend","market":"US","newRecordDate":"2024-05-02","defaultRemindTime":1714570200000,"name":"Novozymes A/S","recordDate":"2024-05-20","payableDate":"2024-05-02","currency":"USD","dateTimestamp":1714536000000,"payDate":"2024-05-20"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVZMY\",market:\"US\",,,undefined,":[{"executeDate":"2016-02-24","recordDate":"2016-02-26","paymentDate":"2016-03-15","value":0.327579,"currency":"USD"},{"executeDate":"2019-02-28","recordDate":"2019-03-01","paymentDate":"2019-03-19","value":0.504374,"currency":"USD"},{"executeDate":"2020-02-27","recordDate":"2020-02-28","paymentDate":"2020-03-17","value":0.519405,"currency":"USD"},{"executeDate":"2021-03-12","recordDate":"2021-03-15","paymentDate":"2021-03-31","value":0.569924,"currency":"USD"},{"executeDate":"2022-03-17","recordDate":"2022-03-18","paymentDate":"2022-04-05","value":0.845217,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVZMY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":1,"buy":0,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":1,"analysts":2,"updateTime":1707019200000}}}